By Zubair Baloch, MD, MASCP
Today's cytopathology is viewed as a clinically-oriented pathology subspecialty that aims to rapidly diagnose a majority of benign and malignant lesions with specimens procured by minimally invasive techniques. The major goal of a cytopathology service is to improve patient care through highly-skilled application of the methods available in cytopathology. This includes familiarizing our clinical colleagues to the possibilities and advantages of cytologic evaluations, as well as realizing the full potential of newer diagnostic modalities to cytologic material.
The ASCP 2018 Annual Meeting session, “Basic and Advanced Organ-based Cytopathology: A Progressive Learning Approach,” on Oct. 3, utilizes a progressive learning format and begins with providing basic concepts of cytology techniques, preparations and morphology for the practicing pathologists, as well as residents and cytotechnologists. This session provides a good platform for trainees, since the Resident Review Series doesn’t include specific cytopathology topics.
The expert faculty with varied specialty interests will discuss and illustrate the most commonly encountered cytology specimens, including gynecologic, exfoliative, and FNA cytology. They will present detailed diagnostic criteria, adequacy requirements, differential diagnosis, and histopathologic correlation. The second half of each talk will focus on the new changes in the terminology of reporting cytology specimens, along with description of ancillary techniques (immunohistochemistry and molecular) that can be used in cytopathology. There will be an ample opportunity for questions and audience participation.
Learn more about the ASCP 2018 Annual Meeting and register here.
Zubair Baloch, MD, MASCP, will present the ASCP 2018 Annual Meeting session titled, “Basic and Advanced Organ-based Cytopathology: A Progressive Learning Approach” on Wednesday, Oct. 3 from 1 to 4:10 p.m. Also presenting are Ricardo Ramon Lastra, MD, Momin Tipu Siddiqui, MD, FASCP, and Christopher Griffith, MD, PhD, FASCP.